Smith Karen L

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Smith Karen L
CIK #0001639637
EDGAR Form CIK 2011 - 2026
3 [0001639637]
4 [0001639637]
Form 3/4/5 Subject 2011 - 2026
Context Therapeutics Inc
Smith Karen L
Skye Bioscience Inc
Sangamo Therapeutics Inc
Aurinia Pharmaceuticals Inc
Tourmaline Bio Inc
Quince Therapeutics Inc
Antares Pharma Inc
Acceleron Pharma Inc
Emergent BioSolutions Inc
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
2026-02-06 Grant 35,000 $0.00
Sangamo Therapeutics Inc SGMO
Common Stock
2025-06-12 Grant 25,000 $0.00
Context Therapeutics Inc CNTX
Stock Option (right to buy) · derivative
2025-06-12 Grant 123,500 $0.00
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
2025-06-12 Grant 50,000 $0.00
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
2025-02-24 Grant 35,000 $0.00
Aurinia Pharmaceuticals Inc AUPH
Common Shares
2024-11-21 Grant 12,135 $0.00
Aurinia Pharmaceuticals Inc AUPH
Director Stock Option (right to buy) · derivative
2024-11-21 Grant 18,641 $0.00
Aurinia Pharmaceuticals Inc AUPH
Common Stock
2024-11-11 Sell 5,241 $8.43 44,182
Aurinia Pharmaceuticals Inc AUPH
Common Stock
2024-11-08 Option exercise 17,913
Aurinia Pharmaceuticals Inc AUPH
Restricted Stock Units · derivative
2024-11-08 Option exercise 17,913 $0.00
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
2024-10-28 Grant 70,000 $0.00
Context Therapeutics Inc CNTX
Stock Option (right to buy) · derivative
2024-09-04 Grant 19,315 $0.00
Skye Bioscience Inc SKYE
Director Stock Option (Right to Buy) · derivative
2024-07-02 Grant 40,000 $0.00
Sangamo Therapeutics Inc SGMO
Common Stock
2024-06-04 Grant 25,000 $0.00
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
2024-06-04 Grant 50,000 $0.00
Aurinia Pharmaceuticals Inc AUPH
Stock Option (right to buy) · derivative
2023-08-18 Grant 28,959 $0.00
Aurinia Pharmaceuticals Inc AUPH
Restricted Stock Units · derivative
2023-08-18 Grant 17,913 $0.00
Tourmaline Bio Inc TALS
Stock Option (Right to Buy) · derivative
2023-06-13 Grant 20,500 $0.00
Sangamo Therapeutics Inc SGMO
Common Stock
2023-06-01 Grant 13,900 $0.00
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
2023-06-01 Grant 27,750 $0.00
showing 20 of 112 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com